Literature DB >> 27122014

Homozygous mutation in the APOA1BP is associated with a lethal infantile leukoencephalopathy.

Ronen Spiegel1,2, Avraham Shaag3, Stavit Shalev4,5, Orly Elpeleg3.   

Abstract

Febrile-induced neurodegenerative diseases are a heterogeneous group of genetic disorders most commonly inborn errors of metabolism that result in irreversible damage involving the central nervous system. Here, we report on five siblings of consanguineous family who developed normally for the first 6-12 months of life then presented with a severe leukoencephalopathy following a trivial febrile illness. Using homozygosity mapping followed by whole exome sequencing, we identified a homozygous c. 281C>A mutation in the APOA1BP gene resulting in substitution of a highly conserved alanine residue with aspartic acid (p.Ala94Asp). APOA1BP encodes for epimerase that catalyzes the R to S epimerization of NAD(P)XH, a crucial step in the dehydration of these toxic metabolites accumulating during cellular metabolism. This is the first report of a defect in the nicotinamide nucleotide repair system in humans.

Entities:  

Keywords:  APOA1BP gene; Homozygosity mapping; Leukoencephalopathy; Neurodegeneration; Nicotine amide nucleotides; Whole exome sequencing

Mesh:

Substances:

Year:  2016        PMID: 27122014     DOI: 10.1007/s10048-016-0483-3

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  13 in total

1.  Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2.

Authors:  Ronen Spiegel; Ophry Pines; Asaf Ta-Shma; Efrat Burak; Avraham Shaag; Jonatan Halvardson; Shimon Edvardson; Muhammad Mahajna; Shamir Zenvirt; Ann Saada; Stavit Shalev; Lars Feuk; Orly Elpeleg
Journal:  Am J Hum Genet       Date:  2012-03-09       Impact factor: 11.025

2.  Enzymatic conversion of a reduced diphosphopyridine nucleotide derivative to reduced diphosphopyridine nucleotide.

Authors:  J O MEINHART; S CHAYKIN; E G KREBS
Journal:  J Biol Chem       Date:  1956-06       Impact factor: 5.157

Review 3.  Leigh syndrome: One disorder, more than 75 monogenic causes.

Authors:  Nicole J Lake; Alison G Compton; Shamima Rahman; David R Thorburn
Journal:  Ann Neurol       Date:  2015-12-15       Impact factor: 10.422

4.  Inhibition of NADP-dependent dehydrogenases by modified products of NADPH.

Authors:  A Yoshida; V Dave
Journal:  Arch Biochem Biophys       Date:  1975-07       Impact factor: 4.013

5.  Occurrence and subcellular distribution of the NADPHX repair system in mammals.

Authors:  Alexandre Y Marbaix; Donatienne Tyteca; Tom D Niehaus; Andrew D Hanson; Carole L Linster; Emile Van Schaftingen
Journal:  Biochem J       Date:  2014-05-15       Impact factor: 3.857

6.  Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I.

Authors:  Mirko Ritter; Christa Buechler; Alfred Boettcher; Stefan Barlage; Anna Schmitz-Madry; Evelyn Orsó; Salim Maa Bared; Gerno Schmiedeknecht; Carsten H Baehr; Gert Fricker; Gerd Schmitz
Journal:  Genomics       Date:  2002-05       Impact factor: 5.736

7.  Extremely conserved ATP- or ADP-dependent enzymatic system for nicotinamide nucleotide repair.

Authors:  Alexandre Y Marbaix; Gaëtane Noël; Aline M Detroux; Didier Vertommen; Emile Van Schaftingen; Carole L Linster
Journal:  J Biol Chem       Date:  2011-10-12       Impact factor: 5.157

Review 8.  Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency.

Authors:  Stefan Kölker; David M Koeller; Jürgen G Okun; Georg F Hoffmann
Journal:  Ann Neurol       Date:  2004-01       Impact factor: 10.422

9.  Genetic evidence for the adhesion protein IgSF9/Dasm1 to regulate inhibitory synapse development independent of its intracellular domain.

Authors:  Archana Mishra; Matthias H Traut; Lore Becker; Thomas Klopstock; Valentin Stein; Rüdiger Klein
Journal:  J Neurosci       Date:  2014-03-19       Impact factor: 6.167

10.  A comprehensive strategy enabling high-resolution functional analysis of the yeast genome.

Authors:  David K Breslow; Dale M Cameron; Sean R Collins; Maya Schuldiner; Jacob Stewart-Ornstein; Heather W Newman; Sigurd Braun; Hiten D Madhani; Nevan J Krogan; Jonathan S Weissman
Journal:  Nat Methods       Date:  2008-07-11       Impact factor: 28.547

View more
  11 in total

Review 1.  Regulation of lipid rafts, angiogenesis and inflammation by AIBP.

Authors:  Longhou Fang; Yury I Miller
Journal:  Curr Opin Lipidol       Date:  2019-06       Impact factor: 4.776

2.  AIBP, NAXE, and Angiogenesis: What's in a Name?

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  Circ Res       Date:  2017-05-26       Impact factor: 17.367

3.  A Case with NAD(P)HX Dehydratase (NAXD) Deficiency: A Newly Defined Mutation in a Novel Neurodegenerative Disorder.

Authors:  Gökçen Oz Tuncer; Nadide Cemre Randa; Seren Aydin; Ayşe Aksoy
Journal:  Mol Syndromol       Date:  2022-02-08

4.  Novel NAXE variants as a cause for neurometabolic disorder: implications for treatment.

Authors:  Joanne Trinh; Sophie Imhoff; Marija Dulovic-Mahlow; Krishna Kumar Kandaswamy; Vera Tadic; Jochen Schäfer; Valerija Dobricic; Achim Nolte; Martin Werber; Arndt Rolfs; Alexander Münchau; Christine Klein; Katja Lohmann; Norbert Brüggemann
Journal:  J Neurol       Date:  2019-11-20       Impact factor: 4.849

5.  NAXE Mutations Disrupt the Cellular NAD(P)HX Repair System and Cause a Lethal Neurometabolic Disorder of Early Childhood.

Authors:  Laura S Kremer; Katharina Danhauser; Diran Herebian; Danijela Petkovic Ramadža; Dorota Piekutowska-Abramczuk; Annette Seibt; Wolfgang Müller-Felber; Tobias B Haack; Rafał Płoski; Klaus Lohmeier; Dominik Schneider; Dirk Klee; Dariusz Rokicki; Ertan Mayatepek; Tim M Strom; Thomas Meitinger; Thomas Klopstock; Ewa Pronicka; Johannes A Mayr; Ivo Baric; Felix Distelmaier; Holger Prokisch
Journal:  Am J Hum Genet       Date:  2016-09-08       Impact factor: 11.025

6.  Evidence that the metabolite repair enzyme NAD(P)HX epimerase has a moonlighting function.

Authors:  Thomas D Niehaus; Mona Elbadawi-Sidhu; Lili Huang; Laurence Prunetti; Jesse F Gregory; Valérie de Crécy-Lagard; Oliver Fiehn; Andrew D Hanson
Journal:  Biosci Rep       Date:  2018-05-08       Impact factor: 3.840

Review 7.  Inborn errors of metabolite repair.

Authors:  Maria Veiga-da-Cunha; Emile Van Schaftingen; Guido T Bommer
Journal:  J Inherit Metab Dis       Date:  2019-12-29       Impact factor: 4.982

8.  NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF-1α signaling in hepatocellular carcinoma.

Authors:  Bo Sun; Lei Yu; Cong Xu; Yi-Ming Li; Yan-Rong Zhao; Mo-Mo Cao; Lian-Yue Yang
Journal:  Cancer Sci       Date:  2021-05-04       Impact factor: 6.716

Review 9.  NAD+ homeostasis in human health and disease.

Authors:  Rubén Zapata-Pérez; Ronald J A Wanders; Clara D M van Karnebeek; Riekelt H Houtkooper
Journal:  EMBO Mol Med       Date:  2021-05-27       Impact factor: 12.137

10.  New perspective in diagnostics of mitochondrial disorders: two years' experience with whole-exome sequencing at a national paediatric centre.

Authors:  Ewa Pronicka; Dorota Piekutowska-Abramczuk; Elżbieta Ciara; Joanna Trubicka; Dariusz Rokicki; Agnieszka Karkucińska-Więckowska; Magdalena Pajdowska; Elżbieta Jurkiewicz; Paulina Halat; Joanna Kosińska; Agnieszka Pollak; Małgorzata Rydzanicz; Piotr Stawinski; Maciej Pronicki; Małgorzata Krajewska-Walasek; Rafał Płoski
Journal:  J Transl Med       Date:  2016-06-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.